# QuidelOrtho

its InflammaDry test detects elevated MMP-9, an inflammatory marker associated with dry eye disease, though a 2026 industry report flagged a supply disruption affecting at least one distribution channel for the product.

Source: https://en.bioecon.ru/companies/quidelortho/
Updated: 2026-07-20

- Country: United States
- Ticker: QDEL

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | $2.73 billion in annual revenue for 2025 | https://www.sec.gov/Archives/edgar/data/1906324/000114036126017095/ef20071326_ars.pdf |
| Headcount | approximately 1,200 service employees globally as of December 28, 2025 | https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm |
| Production site | Manufacturing facilities in the U.S. (Carlsbad, CA; San Diego, CA; Athens, OH; Raritan, NJ; Rochester, NY; Pompano Beach, FL), U.K. (Pencoed, Wales), and China (Changsha) | https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm |
| Certification | Many manufacturing facilities are certified to ISO 13485:2016 and MDSAP medical device standards | https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm |
| Regulatory approval | Facilities are registered with various regulatory bodies, including the FDA and other international and local public health and regulatory agencies | https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm |
| Capacity | The company believes its plant capacity and available space are sufficient to accommodate current growth, maintain quality and support continuity | https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm |
| Funding | The company acquired InflammaDry for approximately $14 million in cash in 2017 | https://ir.quidelortho.com/news/news-release-details/2017/Quidel-Completes-Acquisition-of-InflammaDryR-and-AdenoPlusR-Eye-Health-Businesses/default.aspx |

Independent sources: sec.gov

## Technologies

- [Tear-fluid biopsy](https://en.bioecon.ru/technology/tear-fluid-biopsy/)